CD4 News and Research

RSS
Tired B cells hamper immune response to HIV

Tired B cells hamper immune response to HIV

FDA approves Energex Systems non-drug therapy for HIV research

FDA approves Energex Systems non-drug therapy for HIV research

Discover of key patterns in gene packaging

Discover of key patterns in gene packaging

Asthma risk increases in children treated for HIV

Asthma risk increases in children treated for HIV

Yeast-based vaccine induces immune responses and reduces tumor size in mice

Yeast-based vaccine induces immune responses and reduces tumor size in mice

Zinc finger technology brings personalized HIV therapy a step closer

Zinc finger technology brings personalized HIV therapy a step closer

Patient's own infection-fighting T cells put late-stage melanoma into long-term remission

Patient's own infection-fighting T cells put late-stage melanoma into long-term remission

Scientists cure advanced skin cancer with body's own cells

Scientists cure advanced skin cancer with body's own cells

Without increased funding, California's dominance and public health are threatened, according to new report

Without increased funding, California's dominance and public health are threatened, according to new report

Possible biological explanation for C-Section-linked allergies and asthma found

Possible biological explanation for C-Section-linked allergies and asthma found

Farming mothers may help children beat allergies

Farming mothers may help children beat allergies

Blood-free monitoring as good as blood tests in predicting the course of AIDS

Blood-free monitoring as good as blood tests in predicting the course of AIDS

Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa

Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa

Researchers discover 'reservoir' that allows HIV to remain infectious despite treatment

Researchers discover 'reservoir' that allows HIV to remain infectious despite treatment

GeoVax Labs to launch phase II trials of HIV vaccine candidate

GeoVax Labs to launch phase II trials of HIV vaccine candidate

Tests monitoring viral loads, CD4+ count do not significantly affect survival rates among HIV-positive people

Tests monitoring viral loads, CD4+ count do not significantly affect survival rates among HIV-positive people

Monitoring AIDS treatment by physical symptoms is effective

Monitoring AIDS treatment by physical symptoms is effective

Zimbabwe HIV/AIDS Union calls on groups to provide post-testing services

Zimbabwe HIV/AIDS Union calls on groups to provide post-testing services

T-cell multiplication unexpectedly delayed after infection

T-cell multiplication unexpectedly delayed after infection

Roswell Park Cancer Institute awarded three-years funding for ovarian cancer vaccine

Roswell Park Cancer Institute awarded three-years funding for ovarian cancer vaccine